FDA
approval
· 2022-12-22
FDA Approved: FULVESTRANT — Original Application (Alembic Pharmaceuticals Inc.)
Summary
FDA approves Alembic Pharmaceuticals' original application for a generic Fulvestrant product. Fulvestrant is used to treat hormone receptor-positive metastatic …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for FULVESTRANT (FULVESTRANT)